Skip to content
Tenfell
Awarded contract
Published 27 Feb 2025

NP39724 Generic and Biosimilar Cancer Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · Scotland

Key facts

Awarded
13 Jan 2025
Procedure
Open procedure (framework)
Buyer type
Health

Awarded to 35 suppliers

SupplierValue
Accord-UK Ltd—
FRESENIUS KABI LIMITED—
Pfizer Ltd—
Baxter Healthcare Ltd—
medac Pharma LLP—
Day Lewis Medical Ltd—
Ipsen—
Mercury Pharmaceuticals Limited—
Rosemont Pharmaceuticals Ltd—
Seacross Pharmaceuticals Ltd—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
MSN Labs—
STADA UK - Thornton & Ross—
Viatris UK Healthcare Ltd—
Zentiva—
Sandoz Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Celltrion Healthcare United Kingdom Limited—
Roche Products Ltd—
Tillomed Laboratories ltd—
Organon Pharma (UK) Ltd.—
Celix Pharma Ltd.—
CST Pharma Ltd—
Martindale Pharma—
Chugai Pharma Uk Ltd—
Selective Supplies Ltd—
Neon Healthcare Ltd—
Glenmark Pharmaceuticals Europe Ltd—
Intrapharm Laboratories Ltd—
Aspire Pharma Ltd—
Morningside Pharmaceuticals Limited—
Aspen Pharmacare UK Limited—
Flexipharm Austrading Limited—
Cipla (EU) Ltd—

Description

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Categories (CPV)

Similar open tenders

About The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Public Contracts Scotland (Open Government Licence v3.0). Always read the original notice before responding.